Sign In

Alex Kiselyov

Development and precise delivery of diverse targeted therapies to treat life-threatening and orphan diseases

Professional Background

Dr. Alex Kiselyov is a highly esteemed biointerventionist whose career spans significant advancements in biomedicine. With a profound commitment to innovative treatments for human diseases, Dr. Kiselyov has not only secured over USD 150 million in venture and non-dilutive funding but has also been instrumental in orchestrating due diligence, term sheet negotiations, and in/licensing collaborations. His extensive experience has seen him contribute to 15 marketed studies and human Phase I-III studies across a variety of critical therapeutic areas, including oncology, CNS (central nervous system), cardiovascular health, and orphan disorders.

Having fruitful stints at several prestigious organizations, Dr. Kiselyov has played pivotal roles, including Chief Scientific Officer at Bionaut Labs, where he co-developed groundbreaking approaches to accessing the CNS and treating neuro-oncological and neurodegenerative diseases. With his visionary insights, he has engineered a tetherless 3D microrobotic platform that enhances treatment modalities for complex conditions such as midline and diffuse intrinsic pontine glioma and epilepsy. His innovative techniques extend to the microformulation and local delivery of biologic drug products, including monoclonal antibodies and oligonucleotides, showcasing his versatility and depth in scientific inquiry.

Throughout his illustrious career, Dr. Kiselyov has engaged with cross-disciplinary teams to pioneer breakthroughs in medical technology and therapeutic solutions. He remains a strong advocate for collaborative science that bridges gaps between fields to address the complex challenges of healthcare.

Education and Achievements

Dr. Kiselyov's educational foundation is as impressive as his professional milestones. He pursued post-doctoral studies in Organic and Medicinal Chemistry at Columbia University, and subsequently at the University of Chicago, amplifying his expertise in medicinal chemistry. He holds a PhD in Organic Chemistry from Georgia State University and a Master of Science (MSc) in Organic Chemistry from the esteemed Lomonosov Moscow State University (MSU).

His scientific contributions are prolific; Dr. Kiselyov is an author of over 180 peer-reviewed publications and has more than 100 issued patents and patent applications to his name, in addition to having contributed to seven book chapters. His continuous pursuit of knowledge and innovation highlights his dedication to advancing the scientific community's understanding of complex biological systems.

Achievements

  • Innovation in Disease Treatment: Dr. Kiselyov's focus on designing novel therapeutics for various conditions, from targeted small molecules for facioscapulo humeral dystrophy (FSHD) to obesity treatments based on Oxytocin, illustrates his commitment to transformative healthcare solutions. His expertise in developing synthetic and matrix-free functional skeletal muscle structures opens new avenues in disease modeling and comprehensive treatment strategies.
  • Breakthroughs in Neurology: By co-developing novel strategies to treat neurodegenerative diseases such as Parkinson's and Huntington's disease, Dr. Kiselyov’s work is critical in the quest for effective therapeutic modalities that enhance patient quality of life.
  • Leadership Roles: Holding numerous executive positions in research and development at various leading organizations, such as the Chief Executive Officer at Myocea and pivotal roles at Amgen and deCODE Genetics, Dr. Kiselyov has demonstrated outstanding leadership and strategic direction in the fields of medicinal chemistry and biotechnological innovation. His past contributions to the Scientific Advisory Board at the Alzheimer’s Drug Discovery Foundation further emphasize his influential presence in neurodegenerative research.
  • Magnetically-Responsive Surfaces Production: Dr. Kiselyov has developed concepts for producing magnetically-responsive surfaces that feature complex 2D and pseudo 3D topologies, which have significant implications for biomedical applications across diverse therapeutic domains.

In conclusion, Dr. Alex Kiselyov stands out as a transformative figure in the realms of biomedical science and innovation. His unwavering dedication to advancing human health through innovative treatments and technologies is evidenced by his vast achievements and contributions to both pharmaceutical sciences and the greater medical community.

Related Questions

How did Alex Kiselyov develop his expertise in developing innovative biointerventions for human diseases?
What prompted Alex Kiselyov to pursue a career in biointervention and biomedicine?
In what ways has Alex Kiselyov's work impacted the treatment of neuromuscular diseases?
How has Alex Kiselyov contributed to the field of oncology research throughout his career?
What are the key achievements in Alex Kiselyov's career that highlight his leadership in biotechnology?
Alex Kiselyov
Add to my network

Location

San Diego, California, United States